FRVAX (FRVAX) Stock Price & Analysis
FRVAX (FRVAX) rose 0.20% to USD 9.82 as of July 26, 2026 at 05:07 UTC, according to Nexqual real-time market data.
FRVAX last closed at USD 9.8; the session ranged USD 9.82–9.82 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 9.48–10.02 (NAS). Source: Nexqual, July 26, 2026 at 05:07 UTC.
Key Statistics (as of July 26, 2026 at 05:07 UTC)
| Price | USD 9.82 |
|---|---|
| Change | ▲ 0.20% (up) |
| Previous Close | USD 9.8 |
| Open | USD 9.82 |
| Day Range | USD 9.82 – 9.82 |
| 52-Week Range | USD 9.48 – 10.02 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (FRVAX)
Nexqual's technical model rates FRVAX "SELL" based on 3 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 05:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 23.18 (oversold) |
| vs SMA50 | Below (USD 9.92) |
| MACD | -0.03 (negative) |
Financial Health Score (FRVAX)
Nexqual rates FRVAX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 05:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LIBAX | Columbia Total Return Bond Fund | USD 30.01 | ▼ 0.2% |
| GLCGX | Goldman Sachs Large Cap Growth | USD 31.75 | ▼ 2.58% |
| FRPAX | Franklin Pennsylvania Tax-Free | USD 8.67 | ▼ 0.69% |
| FRCOX | Franklin Colorado Tax-Free Inco | USD 10.43 | ▼ 0.57% |
| FRORX | Franklin Oregon Tax-Free Income | USD 10.31 | ▼ 0.67% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 05:07 UTC. This page is informational and not investment advice.